|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Real estate investments: | ||||||||||||||||||||
| Income producing property | ||||||||||||||||||||
| Held for development | ||||||||||||||||||||
| Construction in progress | ||||||||||||||||||||
| Real estate investments | ||||||||||||||||||||
| Real estate investments, at cost | ||||||||||||||||||||
| Accumulated depreciation | ||||||||||||||||||||
| Net real estate investments | ||||||||||||||||||||
| Real estate investments held for sale | ||||||||||||||||||||
| Assets of discontinued operations | ||||||||||||||||||||
| Liabilities of discontinued operations | ||||||||||||||||||||
| Total assets of discontinued operations | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Notes receivable, net | ||||||||||||||||||||
| Construction receivables, including retentions, net | ||||||||||||||||||||
| Construction contract costs and estimated earnings in excess of billings | ||||||||||||||||||||
| Equity method investments | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Finance lease right-of-use assets | ||||||||||||||||||||
| Acquired lease intangible assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Indebtedness, net | ||||||||||||||||||||
| Liabilities of discontinued operations | ||||||||||||||||||||
| Liabilities related to assets held for sale | ||||||||||||||||||||
| Liabilities of discontinued operations | ||||||||||||||||||||
| Total liabilities of discontinued operations | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Construction payables, including retentions | ||||||||||||||||||||
| Billings in excess of construction contract costs and estimated earnings | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Finance lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.01 par value, 100,000,000 shares authorized: 6.75% Series A Cumulative Redeemable Perpetual Preferred Stock, 9,980,000 shares authorized; 6,843,418 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock, $0.01 par value, 500,000,000 shares authorized; 74,594,185 and 80,166,778 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Distributions in excess of earnings | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interests in investment entities | ||||||||||||||||||||
| Noncontrolling interests in Operating Partnership | ||||||||||||||||||||
| Total Equity | ||||||||||||||||||||
| Total Liabilities and Equity |
Loading...
